Sun Pharma Advanced Research Co. Ltd. Press Release Dec 17 2024

Published December 17, 2024 at 3:23 a.m. UTC

Source: NSE India

Sun Pharma Advanced Research Company Limited has informed the Exchange regarding a press release dated December 17, 2024, titled "Press Release - Signing of Binding Letter of Intent for Preclinical Oncology Asset".

View Attachment

4:["$","main",null,{"className":"seo-shell seo-template-news","children":[["$","script",null,{"type":"application/ld+json","className":"seo-jsonld","dangerouslySetInnerHTML":{"__html":"{\"@context\":\"https://schema.org\",\"@type\":\"NewsArticle\",\"headline\":\"Sun Pharma Advanced Research Co. Ltd. Press Release Dec 17 2024\",\"description\":\"Sun Pharma Advanced Research Company Limited has informed the Exchange regarding a press release dated December 17, 2024, titled \\\"Press Release - Signing of Binding Letter of Intent for Preclinical Oncology Asset\\\".\",\"url\":\"https://6ix.com/news/sun-pharma-advanced-research-co-ltd-press-release-dec-17-2024\",\"datePublished\":\"2024-12-17T03:23:04.000Z\",\"articleSection\":\"Business\",\"about\":{\"@type\":\"Corporation\",\"name\":\"Sun Pharma Advanced Research Co. Ltd.\",\"url\":\"https://6ix.com/stock/nse-sparc/sun-pharma-advanced-research-company-limited\",\"tickerSymbol\":\"NSE:SPARC\"},\"publisher\":{\"@type\":\"Organization\",\"name\":\"6ix\",\"url\":\"https://6ix.com\",\"logo\":{\"@type\":\"ImageObject\",\"url\":\"https://6ix.com/images/social-banner.png?v=2\"}}}"}}],["$","div",null,{"className":"seo-page-frame","children":[null,[["$","style",null,{"dangerouslySetInnerHTML":{"__html":"$d"}}],["$","div",null,{"dangerouslySetInnerHTML":{"__html":"$e"}}]]]}]]}] 7:null